Hard to Treat Diseases (Hard to Treat Diseases) EPS (Basic) : $ (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases EPS (Basic)?

Hard to Treat Diseases's basic earnings per share (Basic EPS) for the three months ended in . 20 was $0.00. Hard to Treat Diseases does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Hard to Treat Diseases's EPS (Diluted) for the three months ended in . 20 was $0.00. Hard to Treat Diseases does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Hard to Treat Diseases's EPS without NRI for the three months ended in . 20 was $0.00. Hard to Treat Diseases does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Hard to Treat Diseases EPS (Basic) Historical Data

The historical data trend for Hard to Treat Diseases's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases EPS (Basic) Chart

Hard to Treat Diseases Annual Data

Trend

EPS (Basic)

Hard to Treat Diseases Quarterly Data

EPS (Basic)

Hard to Treat Diseases EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hard to Treat Diseases's Basic EPS for the fiscal year that ended in . 20 is calculated as

Basic EPS (A: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(	-	)	/	0
	=

Hard to Treat Diseases's Basic EPS for the quarter that ended in . 20 is calculated as

Basic EPS (Q: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(	-	)	/	0
	=

Hard to Treat Diseases (OTCPK:HTDS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Hard to Treat Diseases EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762

Website

http://www.htdsmedical.com

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines